Securities Class Actions

搜索文档
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” Marketing of Wegovy Triggers Securities Class Actions – HIMS Investors with Losses Encouraged to Contact Hagens Berman
GlobeNewswire News Room· 2025-07-29 04:34
SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company’s executives. The cases seeks to represent investors who purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025. The lawsuits follow an announcement by Novo Nordisk, the Danish maker of the FDA-approved weight-loss medication Wegovy® (a GLP-1 treatment for obesity), that it terminated i ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL
GlobeNewswire News Room· 2025-06-06 23:36
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apple and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On March 7, 2025, App ...